According to the government, Fosun Pharma delivered the first batch of about 770,000 doses of Fubitai bivalent vaccine to Hong Kong today (25th). The government plans to start vaccinating citizens with the bivalent vaccine in early December. Details will be announced later .
According to expert advice, the bivalent vaccine of Fubitai can be used as another option for the fourth dose of vaccine (or the third dose of vaccine for recovered people) according to the current vaccination schedule for eligible persons aged 12 or above, but they are still You can choose to be vaccinated with Sinovac or Fubitai original strain vaccine.
New crown vaccine: The picture is a photo released by the Associated Press on August 26, 2022, showing the packaging of a new version of the bivalent new crown vaccine in a Michigan factory in the United States. The vaccine was developed by the American pharmaceutical company Pfizer and the German biotech company BioNTech. It targets the new crown Virus variant strains Omicron subtypes BA.4 and BA.5, while protecting against the original strain.
(AP)
Vaccination details will be announced later
According to the government, Fosun Pharma delivered the first batch of about 770,000 doses of Fosun Pharma/German pharmaceutical company BioNTech's Fubitai original strain/Omicron variant BA.4-5 bivalent vaccine today (25th) (Comirnaty Original/ Omicron BA.4-5 (15/15 micrograms)/dose Dispersion for Injection COVID-19 mRNA Vaccine (nucleoside modified)) arrived at Hong Kong.
After the approved Bivalent vaccine arrived in Hong Kong today, government personnel immediately conducted inspections and verifications in accordance with established procedures to ensure that the vaccine complies with product specifications and relevant cold chain transportation standards.
The government will also store the vaccines in certified ultra-low temperature freezers, and keep them properly at the temperature specified by the pharmaceutical manufacturer.
The government plans to start vaccinating citizens with bivalent vaccines in early December, and details will be announced later.
According to expert advice, the bivalent vaccine of Fubitai can be used as another option for the fourth dose of vaccine (or the third dose of vaccine for recovered persons) according to the current vaccination schedule for eligible persons aged 12 or above, but they You can still choose to be vaccinated with Sinovac or Fubitai original strain vaccine.
People aged 18 to 49 take the fourth injection after considering two factors
Experts recommend that immunocompromised persons aged 50 or over and those aged 12 or over receive a fourth dose of the vaccine (or a third dose for those who have recovered).
In addition, people aged 18 to 49 can also receive the fourth dose of the vaccine after considering their own risks and benefits, such as higher exposure risks or personal needs.
The government has procured a total of 1.9 million doses of Fubita bivalent vaccine from pharmaceutical companies, and the remaining doses are expected to arrive in Hong Kong by the end of this year.
The government said it would closely monitor the demand for bivalent vaccines and purchase more if necessary.
▼November 22, the last day of the Thai tour group visiting Hong Kong, went to Tsuen Wan to play side stove▼
+39
The University of Hong Kong’s research reveals that the overall death toll has increased during the COVID-19 period. Ben En advocates the maintenance of mandatory testing for non-emergency services︱58 buildings are on the list involving luxury houses such as Butcher Garden, Bachelor’s Terrace, and Emerald Garden. Li Xiayin's test was negative in Baguio Bay, Jialong Court, Cha Kwo Ling Building and other 18 sewage tests were positive, 40,000 people need to quickly test the epidemic situation｜8878 cases returned to the level of 8000 cases and 16 more deaths